INS Share PerformanceMore
|52 week high||328.55 26/09/16|
|52 week low||195.25 05/02/16|
|52 week change||11.50 (5.54%)|
|4 week volume||222,543 07/11/16|
Media for (INS)
Latest News« previous» nextMore
21/11/2016 - 07:00 RNS
RNS Number: 6540P Instem plc 21 November 2016 21 November 2016 Instem plc ("Instem", the "Company" or the "Group") Trading Statement The Group's interim results announcement in September referred to a slow-down in the early phase clinical market that is served by Instem Clinical, which had impacted Instem Clinical's trading performance. At the time of...
22/09/2016 - 06:00 RNS
RNS Number: 5032K Instem plc 22 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Instem plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or dispos...
21/09/2016 - 07:08 RNS
RNS Number: 4166K Instem plc 21 September 2016 Instem plc ("Instem", the "Company" or the "Group") Issue of Equity and Total Voting Rights Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that, following the exercise of share options by employees, 60,446 ordinary shares of 10p each in the Co...
19/09/2016 - 13:58 Interactive Investor
Instem remains bullish following a great first half and the City thinks its high-flying share price has further upside, repor...
19/09/2016 - 06:46 StockMarketWire
Instem's revenues increased 21% to 9.1m in the six months to the end of June with recurring revenues up 6% at 5.3m. EBITD...
19/09/2016 - 06:00 RNS
RNS Number: 1341K Instem plc 19 September 2016 Instem plc ("Instem", the "Company" or the "Group") Half Yearly Report Instem plc (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces its unaudited half year results for the six months ended 30 June 2016. Financial Highlights Revenues increased 21% to 9.1m...
05/09/2016 - 14:48 StockMarketWire
Instem, a leading provider of IT solutions to the global early development healthcare market, has acquired Notocord. The t...
05/09/2016 - 14:40 RNS
RNS Number: 9946I Instem plc 05 September 2016 Instem plc ("Instem") Earnings Enhancing Acquisition of Notocord Systems SAS ("Notocord") Acquisition of software provider in pre-clinical studies Instem (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that it has acquired Notocord (the "Acquisition")...
|Dividend yield||0 %|
Equity Research (INS)
Instem has announced solid interim results. Revenues grew by 21% YoY, accompanied by a 34% improvement in EBITDA. Activity in the pre-clinical segment remains strong, as evidenced by the multi-year...
Instem, a leading provider of software and services to the earlystage drug development healthcare market, has announced the acquisition of France-based Notocord, a profitable software business active...
Instem has acquired a small software business, Samarind, which is active in the market for Regulatory Information Management – helping pharmaceutical companies deliver required details about products...
- 1 of 4
Latest discussion posts More
“"I first spoke to LSE:INS:Instem early last year. The AIM-listed company was worth A#22 million and demand for its software, which helps drug companies develop commercial drugs ...”▼
Codes & Symbols
|Symbols||INS, LSE:INS, INS.L, INS:LN, LON:INS, XLON:INS|